exercise timing glp-1 medications effectiveness 2025 Frontiers Monitoring Report: GLP-1 RA Prescribing

E., Rossi, A., Assi, E., Zuccotti, G

McCall McPhereson: Yeah, so let's say standard is, you know, we use compounded, so we use 25 units

While WuXi TIDES remained the dominant volume player, Bachem, CordenPharma, AmbioPharm, and PolyPeptide all reported increased RFP activity from US clients seeking Western supply chain alternatives a structural tailwind that the report identifies as geopolitical considerations driving demand for Western CDMOs

Specifically, INF- released by CD8 + T cells downregulated the expression of SLC7A11 and SLC3A2, leading to a decrease in GSH and an increase in lipid peroxidation

Why MDMA & Other Psychedelic Therapies May NOT Work for You (Part 1 of 2) Psychedelic therapy is not a cure-all for mental health conditions